Page last updated: 2024-10-25

clenbuterol and Mycoplasma dispar Infection

clenbuterol has been researched along with Mycoplasma dispar Infection in 1 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Research Excerpts

ExcerptRelevanceReference
"children with mycoplasma pneumonia were assigned to the control group (38 cases) and the treatment group (32 case)."2.79[Effect of Zhifei mixture combined western drugs on symptoms and signs of children with mycoplasma pneumonia]. ( Cui, H; Ding, YX; Jiang, WX; Liu, XH; Wang, ZW; Yao, YQ; Yu, Y; Zhang, ZH, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yao, YQ1
Wang, ZW1
Ding, YX1
Yu, Y1
Jiang, WX1
Liu, XH1
Zhang, ZH1
Cui, H1

Trials

1 trial available for clenbuterol and Mycoplasma dispar Infection

ArticleYear
[Effect of Zhifei mixture combined western drugs on symptoms and signs of children with mycoplasma pneumonia].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2014, Volume: 34, Issue:5

    Topics: Ambroxol; Anti-Bacterial Agents; Azithromycin; Bronchodilator Agents; Child; Clenbuterol; Drugs, Chi

2014